Recombinant HIV1 Nef protein (Beta-Galactosidase) (ab49060)

製品の概要

法規制情報

製品の詳細

  • 由来
    Recombinant
  • 由来
    Escherichia coli
  • アミノ酸配列
    • 配列の追加情報
      Fused with β-galactosidase at the N-terminus.

特性

Our Abpromise guarantee covers the use of ab49060 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • 生理活性
    Reacts strongly with human HIV positive serum.
  • アプリケーション

    ELISA

    Western blot

  • 精製度
    > 95 % SDS-PAGE.

  • 製品の状態
    Liquid
  • 備考
    Reacts strongly with human HIV positive serum.
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

    Preservative: None
    Constituents: 0.014M Beta mercaptoethanol, 0.01M Sodium carbonate, 0.01M EDTA

関連情報

  • 別名
    • C terminal core protein
    • F protein
    • Nef
    • Negative factor
    • p27
    see all
  • 関連性
    Nef is a early protein that appears to play a role in optimizing the host cell environment for viral replication without causing cell death by apoptosis. Nef enhances virus infectivity and pathogenicity. It down modulates surface MHC I molecules and internalized molecules are sequested to the trans-Golgi network. The number of cell surface CD4 antigen are decreased by interacting with the Src family kinase LCK thereby inducing LCK CD4 dissociation and by increasing clathrin-dependent endocytosis of this antigen to target it to lysosomal degradation.

参考文献

ab49060 has not yet been referenced specifically in any publications.

レビューと Q&A

There are currently no Customer reviews or Questions for ab49060.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録